Incyte Biosciences Canada today announced that Health Canada has granted a Notice of Compliance for OPZELURA® (ruxolitinib ...

Systemic JAK inhibitor therapy with tofacitinib was associated with the most favorable outcomes among patients with extensive vitiligo.

In addition, on 24 September, the NDA for vitiligo indication of ruxolitinib cream has been accepted by the National Medical Products Administration of China (NMPA). In accordance with the relevant ...

Clarkson has been open after previous health battles including being hospitalised in Majorca and and fighting his weight ...

Painful beauty customs over the years include foot binding, fontage, arsenic pads, lead makeup, Brazilian waxes, and much ...

The discount retailer has released a range of toys with different conditions, including vitiligo, cochlear implants, and ...

Parents are praising the supermarket for 'helping people feel seen' thanks to its range of inclusive toy dolls ...

A study of ruxolitinib cream in patients with lichen planus indicated that the topical JAK inhibitor is a promising potential ...

Aldi has been praised by shoppers after it unveiled a new range of toys in its stores. The supermarket has started stocking dolls which have birthmarks and other conditions as part of its new range of ...

Upadacitinib, a drug used to treat atopic dermatitis (AD), may potentially induce alopecia areata, a case study suggests.

If farmers are criticized for the pollution caused by stubble burning, why is there no similar outrage toward industrialists ...